106 related articles for article (PubMed ID: 17178893)
1. Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice.
Shi J; Liu Y; Zheng Y; Guo Y; Zhang J; Cheung PT; Xu R; Zheng D
Cancer Res; 2006 Dec; 66(24):11946-53. PubMed ID: 17178893
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus-mediated anti-DR5 chimeric antibody expression suppresses human tumor growth in nude mice.
Lv F; Qiu Y; Zhang Y; Liu S; Shi J; Liu Y; Zheng D
Cancer Lett; 2011 Mar; 302(2):119-27. PubMed ID: 21306822
[TBL] [Abstract][Full Text] [Related]
3. Humanization of an agonistic anti-death receptor 4 single chain variable fragment antibody and avidity-mediated enhancement of its cell death-inducing activity.
Lee SH; Park DW; Sung ES; Park HR; Kim JK; Kim YS
Mol Immunol; 2010 Jan; 47(4):816-24. PubMed ID: 19864027
[TBL] [Abstract][Full Text] [Related]
4. CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors.
Haynes NM; Hawkins ED; Li M; McLaughlin NM; Hämmerling GJ; Schwendener R; Winoto A; Wensky A; Yagita H; Takeda K; Kershaw MH; Darcy PK; Smyth MJ
J Immunol; 2010 Jul; 185(1):532-41. PubMed ID: 20505139
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.
Ye JJ; Liang SJ; Guo N; Li SL; Wu AM; Giannini S; Sachdev D; Yee D; Brünner N; Ikle D; Fujita-Yamaguchi Y
Horm Metab Res; 2003; 35(11-12):836-42. PubMed ID: 14710366
[TBL] [Abstract][Full Text] [Related]
6. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
Zhang Y; Ma H; Zhang J; Liu S; Liu Y; Zheng D
Life Sci; 2008 Jun; 82(23-24):1154-61. PubMed ID: 18485417
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.
Shi J; Zheng D; Liu Y; Sham MH; Tam P; Farzaneh F; Xu R
Cancer Res; 2005 Mar; 65(5):1687-92. PubMed ID: 15753363
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells.
Frade R; Rousselet N; Jean D
Cancer Gene Ther; 2008 Sep; 15(9):591-604. PubMed ID: 18617916
[TBL] [Abstract][Full Text] [Related]
9. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
10. Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.
Afanasieva TA; Wittmer M; Vitaliti A; Ajmo M; Neri D; Klemenz R
Gene Ther; 2003 Oct; 10(21):1850-9. PubMed ID: 12960975
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
Hao XK; Liu JY; Yue QH; Wu GJ; Bai YJ; Yin Y
Prostate; 2006 Jun; 66(8):858-66. PubMed ID: 16491483
[TBL] [Abstract][Full Text] [Related]
12. A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells.
Kikuchi Y; Uno S; Yoshimura Y; Otabe K; Iida S; Oheda M; Fukushima N; Tsuchiya M
Biochem Biophys Res Commun; 2004 Mar; 315(4):912-8. PubMed ID: 14985099
[TBL] [Abstract][Full Text] [Related]
13. [Construction and expression of anti-tumor necrosis factor related apoptosis-inducing ligand receptor death receptor 5 chimeric antibody in eukaryotic cells].
Chen F; Guo YB; Liu SL; Zheng DX; Liu YX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):690-5. PubMed ID: 19180918
[TBL] [Abstract][Full Text] [Related]
14. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
Zhang Y; Zhang B
Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice.
Lee K; Yun ST; Kim YG; Yoon Y; Jo EC
Hepatology; 2006 May; 43(5):1063-73. PubMed ID: 16628632
[TBL] [Abstract][Full Text] [Related]
16. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
[TBL] [Abstract][Full Text] [Related]
17. Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response.
Stagg J; Sharkey J; Pommey S; Young R; Takeda K; Yagita H; Johnstone RW; Smyth MJ
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16254-9. PubMed ID: 18838682
[TBL] [Abstract][Full Text] [Related]
18. Antibody gene therapy: an attractive approach for the treatment of cancers and other chronic diseases.
Zheng D
Cell Res; 2007 Apr; 17(4):303-6. PubMed ID: 17404600
[No Abstract] [Full Text] [Related]
19. Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model.
Zhang L; Zhang X; Barrisford GW; Olumi AF
Cancer Lett; 2007 Jun; 251(1):146-57. PubMed ID: 17184908
[TBL] [Abstract][Full Text] [Related]
20. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
